Reduction of the initial febrile response to OKT3 with indomethacin.
First
M R
MR
Division of Nephrology and Hypertension, University of Cincinnati Medical Center, OH 45267-0585.
Schroeder
T J
TJ
Hariharan
S
S
Weiskittel
P
P
D000082:Acetaminophen / Q000627:therapeutic use; D000328:Adult; D003404:Creatinine / Q000097:blood; D004155:Diphenhydramine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005334:Fever / Q000209:etiology* / Q000517:prevention & control; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007213:Indomethacin / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use
D016853:Muromonab-CD3; D000082:Acetaminophen; D004155:Diphenhydramine; D003404:Creatinine; D008775:Methylprednisolone; D007213:Indomethacin